| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.96▲ | 3.97▲ | 3.97▲ | 4.04▼ | 4.05▼ |
| MA10 | 3.97▲ | 3.98▼ | 4.00▼ | 4.05▼ | 4.23▼ |
| MA20 | 3.97▲ | 4.01▼ | 4.03▼ | 4.08▼ | 4.25▼ |
| MA50 | 4.00▼ | 4.05▼ | 4.08▼ | 4.23▼ | 3.48▲ |
| MA100 | 4.03▼ | 4.07▼ | 4.04▼ | 4.24▼ | N/A |
| MA200 | 4.06▼ | 4.08▼ | 4.16▼ | 3.61▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.004▼ | -0.007▼ | -0.002▼ | -0.073▼ |
| RSI | 50.624▲ | 43.850▼ | 44.006▼ | 43.995▼ | 49.934▼ |
| STOCH | 41.667 | 36.608 | 28.279 | 43.492 | 39.760 |
| WILL %R | -35.000 | -55.172 | -62.857 | -66.234 | -42.857 |
| CCI | 49.278 | -64.671 | -90.116 | -49.296 | -42.362 |
|
Tuesday, August 04, 2026 09:05 AM
Executing IND-enabling activities for next-generation PI3Kα pan-mutant selective candidates OKI-345 in breast cancer and OKI-355 in vascular ...
|
|
Wednesday, July 15, 2026 10:02 AM
Key Points Interested in OnKure Therapeutics, Inc.? Here are five stocks we like better. OnKure Therapeutics is advancing two lead allosteric PI3Kα inhibitors, OKI-355 for vascular anomalies and ...
|
|
Thursday, July 02, 2026 05:30 AM
BOULDER, Colo., July 02, 2026 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/08/26 | 4.015 | 4.015 | 3.94 | 3.98 | 26,822 |
| 12/08/26 | 4.10 | 4.10 | 3.91 | 3.93 | 53,263 |
| 11/08/26 | 4.07 | 4.11 | 3.95 | 4.09 | 79,449 |
| 10/08/26 | 4.07 | 4.1708 | 3.98 | 4.06 | 141,967 |
| 07/08/26 | 4.20 | 4.26 | 4.01 | 4.14 | 84,006 |
| 06/08/26 | 4.17 | 4.27 | 3.90 | 4.15 | 85,936 |
| 05/08/26 | 4.13 | 4.3315 | 3.8801 | 4.16 | 249,938 |
| 04/08/26 | 4.11 | 4.49 | 4.09 | 4.10 | 201,141 |
| 03/08/26 | 3.90 | 4.08 | 3.75 | 4.02 | 155,708 |
| 31/07/26 | 3.99 | 4.005 | 3.72 | 3.82 | 239,215 |
|
|
||||
|
|
||||
|
|